Sökresultat - Dieter Volc
- Visas 1 - 4 av 4 resultat
-
1
-
2
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study av Werner Poewe, Dieter Volc, Klaus Seppi, Rossella Medori, Petra Lührs, Alexandra Kutzelnigg, Atbin Djamshidian, Caroline Thun-Hohenstein, Wassilios G. Meissner, Olivier Rascol, Achim Schneeberger, Günther Staffler, Werner Poewe, Klaus Seppi, Atbin Djamshidian, Roberto deMarzi, Beatrice Heim, Stephanie Mangesius, Raphaela Stolz, Katarzyna Wachowicz, Dieter Volc, Caroline Thun-Hohenstein, Constanze Riha, Achim Schneeberger, Vera Bürger, Gergana Galabova
Publicerad 2021Artigo -
3
A Phase 1 Randomized Trial of Specific Active <scp>α‐Synuclein</scp> Immunotherapies <scp>PD01A</scp> and <scp>PD03A</scp> in Multiple System Atrophy av Wassilios G. Meissner, Anne Pavy‐Le Traon, Alexandra Foubert‐Samier, Gergana Galabova, Monique Galitzky, Alexandra Kutzelnigg, Brice Laurens, Petra Lührs, Rossella Medori, Patrice Péran, Umberto Sabatini, Sylvain Vergnet, Dieter Volc, Werner Poewe, Achim Schneeberger, Günther Staffler, O. Rascol
Publicerad 2020Artigo -
4
Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease av Philipp Mahlknecht, Raimund Pechlaner, Sanne Boesveldt, Dieter Volc, Bernardette Pinter, Eva Reiter, Christoph Müller, Florian Krismer, Henk W. Berendse, Jacobus J. van Hilten, Albert Wuschitz, Wolfgang Schimetta, Birgit Högl, Atbin Djamshidian, Michael Nocker, Georg Göbel, Arno Gasperi, Stefan Kiechl, Johann Willeit, Werner Poewe, Klaus Seppi
Publicerad 2016Revisão
Sökverktyg:
Relaterade ämnen
Medicine
Internal medicine
Pathology
Adverse effect
Alternative medicine
Antibody
Antibody titer
Disease
Immunology
Parkinson's disease
Placebo
Titer
Tolerability
Atrophy
Biochemistry
Biology
Botany
Chemistry
Clinical trial
Degenerative disease
Diagnostic test
Enzyme
Epitope
Gastroenterology
Identification (biology)
Immune system
Immunogenicity
Immunotherapy
Levodopa
NAD+ kinase